Stay updated with breaking news from Lawrencef Eichenfield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW ORLEANS — Patients with atopic dermatitis experienced a rapid and sustained reduction in itch with topical roflumilast cream treatment, according to phase 3 study results presented at the American Academy of Dermatology Annual Meeting.“The study supports that roflumilast cream 0.15% showed efficacy, good safety and very good tolerance for children and adults with atopic dermatitis
Emerging research suggests that there may be a role for oral omega-3 in reducing these side effects, which include cheilitis and dry skin.
Ruxolitinib cream provides quick itch relief for Black patients with atopic dermatitis, researchers report.
/PRNewswire/ -- Following the success of last year's conference, Medscape Education will host the second annual spring edition of the Innovations in...
'These findings highlight the importance of detailed assessment of specific areas affected by AD to personalize treatment approaches to the needs of patients,' Dr Lawrence Eichenfield said.